News
In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has ...
FDA Commissioner Marty Makary said Thursday that his agency is preparing to release a new regulatory framework within the ...
CEO Önal said Türk Telekom had a ‘spectacular’ start to the year, primarily driven by the maintained strength in fixed ...
Tezepelumab demonstrated rapid and sustained clinical improvements in nasal polyp burden and symptom control, with effects ...
The treatment, branded as Emrelis, belongs to a class of drugs known as antibody-drug conjugates, which act as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results